These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
169 related items for PubMed ID: 10774568
1. Intrahepatic chemotherapy with floxuridine, leucovorin and dexamethasone in continuous infusion and mitomycin-C bolus in unresectable hepatic metastases from colorectal cancer: a phase II study. Bertuccelli M, Falcone A, Campoccia S, Conti M, Brunetti I, Caramella D, Giulianotti PC, Mosca F, Bartolozzi C, Conte PF. Tumori; 1999; 85(6):473-7. PubMed ID: 10774568 [Abstract] [Full Text] [Related]
2. Hepatic arterial floxuridine and leucovorin for unresectable liver metastases from colorectal carcinoma. New dose schedules and survival update. Kemeny N, Seiter K, Conti JA, Cohen A, Bertino JR, Sigurdson ER, Botet J, Chapman D, Mazumdar M, Budd AJ. Cancer; 1994 Feb 15; 73(4):1134-42. PubMed ID: 8313315 [Abstract] [Full Text] [Related]
3. Hepatic arterial infusion of floxuridine and dexamethasone plus high-dose Mitomycin C for patients with unresectable hepatic metastases from colorectal carcinoma. Kemeny N, Eid A, Stockman J, Gonen M, Schwartz L, Tetzlaff E, Paty P. J Surg Oncol; 2005 Aug 01; 91(2):97-101. PubMed ID: 16028279 [Abstract] [Full Text] [Related]
4. Phase II trial of hepatic arterial infusion of fluorouracil and recombinant human interferon alfa-2b for liver metastases of colorectal cancer refractory to systemic fluorouracil and leucovorin. Patt YZ, Hoque A, Lozano R, Pozdur R, Chase J, Carrasco H, Chuang V, Delpassand ES, Ellis L, Curley S, Roh M, Jones DV. J Clin Oncol; 1997 Apr 01; 15(4):1432-8. PubMed ID: 9193336 [Abstract] [Full Text] [Related]
5. Basic research supported developments of chemotherapy in nonresectable isolated colorectal liver metastases to a protocol of hepatic artery infusion using mitoxantrone, 5-FU + folinic acid and mitomycin C. Link KH, Kornmann M, Leder G, Pillasch AF, Sunelaitis E, Schatz M, Pressmar J, Beger HG. Gan To Kagaku Ryoho; 1999 Feb 01; 26(3):269-81. PubMed ID: 10065089 [Abstract] [Full Text] [Related]
7. A pilot study of hepatic artery floxuridine combined with systemic 5-fluorouracil and leucovorin. A potential adjuvant program after resection of colorectal hepatic metastases. Kemeny N, Conti JA, Sigurdson E, Cohen A, Seiter K, Lincer R, Niedzwiecki D, Botet J, Chapman D, Costa P. Cancer; 1993 Mar 15; 71(6):1964-71. PubMed ID: 8443746 [Abstract] [Full Text] [Related]
12. Phase I trial of adjuvant hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone plus systemic oxaliplatin, 5-fluorouracil and leucovorin in patients with resected liver metastases from colorectal cancer. Kemeny N, Capanu M, D'Angelica M, Jarnagin W, Haviland D, Dematteo R, Fong Y. Ann Oncol; 2009 Jul 30; 20(7):1236-41. PubMed ID: 19233901 [Abstract] [Full Text] [Related]
13. Sequential intrahepatic fluorodeoxyuridine and systemic fluorouracil plus leucovorin for the treatment of metastatic colorectal cancer confined to the liver. O'Connell MJ, Nagorney DM, Bernath AM, Schroeder G, Fitzgibbons RJ, Mailliard JA, Burch P, Bolton JS, Colon-Otero G, Krook JE. J Clin Oncol; 1998 Jul 30; 16(7):2528-33. PubMed ID: 9667274 [Abstract] [Full Text] [Related]
14. Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer. Kemeny N, Jarnagin W, Paty P, Gönen M, Schwartz L, Morse M, Leonard G, D'Angelica M, DeMatteo R, Blumgart L, Fong Y. J Clin Oncol; 2005 Aug 01; 23(22):4888-96. PubMed ID: 16009951 [Abstract] [Full Text] [Related]
15. Continuous delivery of venous 5-fluorouracil and arterial 5-fluorodeoxyuridine for hepatic metastases from colorectal cancer: feasibility and tolerance in a randomized phase II trial comparing flat versus chronomodulated infusion. Focan C, Levi F, Kreutz F, Focan-Henrard D, Lobelle JP, Adam R, Dallemagne B, Jehaes C, Markiewicz S, Weerts J, Bismuth H, Jasmin C, Misset JL. Anticancer Drugs; 1999 Apr 01; 10(4):385-92. PubMed ID: 10378673 [Abstract] [Full Text] [Related]
16. In defense of hepatic arterial infusion for hepatic metastases of colorectal cancer. Kemeny N. J Natl Compr Canc Netw; 2010 May 01; 8(5):507-9. PubMed ID: 20495081 [No Abstract] [Full Text] [Related]
17. Regional chemotherapy for colorectal hepatic metastases: evidence for improved survival with new drug combinations. Sutanto-Ward E, Arisawa Y, Tremiterra S, Sigurdson ER. Ann Surg Oncol; 1996 Jan 01; 3(1):36-43. PubMed ID: 8770300 [Abstract] [Full Text] [Related]
18. Phase I study of hepatic arterial infusion of floxuridine and dexamethasone with systemic irinotecan for unresectable hepatic metastases from colorectal cancer. Kemeny N, Gonen M, Sullivan D, Schwartz L, Benedetti F, Saltz L, Stockman J, Fong Y, Jarnagin W, Bertino J, Tong W, Paty P. J Clin Oncol; 2001 May 15; 19(10):2687-95. PubMed ID: 11352961 [Abstract] [Full Text] [Related]
19. Isolated hepatic perfusion for unresectable hepatic metastases from colorectal cancer. Bartlett DL, Libutti SK, Figg WD, Fraker DL, Alexander HR. Surgery; 2001 Feb 15; 129(2):176-87. PubMed ID: 11174711 [Abstract] [Full Text] [Related]
20. Continuous intrahepatic infusion of floxuridine and leucovorin through an implantable pump for the treatment of hepatic metastases from colorectal carcinoma. Kemeny N, Cohen A, Bertino JR, Sigurdson ER, Botet J, Oderman P. Cancer; 1990 Jun 01; 65(11):2446-50. PubMed ID: 2140070 [Abstract] [Full Text] [Related] Page: [Next] [New Search]